ヒトパピローマウイルス(HPV)関連がん:世界の治験レビュー(2017年下半期版)

◆英語タイトル:Human Papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H2, 2017
◆商品コード:GDHC4600CTIDB
◆発行会社(調査会社):GlobalData
◆発行日:2017年9月22日
◆ページ数:101
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD7,500 ⇒換算¥825,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、世界におけるヒトパピローマウイルス(HPV)関連がん治療の臨床試験動向について調査・分析し、アジア/ヨーロッパ/アメリカ/中南米の主要国における治験件数、フェーズ別の治験件数、進捗状況別の治験件数、有望なスポンサー、有望な薬剤、治験関連の最新ニュース、主要企業分析、主要な治験プロファイル分析などの情報をご提供致します。
・ヒトパピローマウイルス(HPV)関連がん:主要地域別治験動向
・ヒトパピローマウイルス(HPV)関連がん:アジア市場
・ヒトパピローマウイルス(HPV)関連がん:ヨーロッパ市場
・ヒトパピローマウイルス(HPV)関連がん:アメリカ市場
・ヒトパピローマウイルス(HPV)関連がん:中南米市場
・ヒトパピローマウイルス(HPV)関連がん:中東・アフリカ市場
・ヒトパピローマウイルス(HPV)関連がん:段階(フェーズ)別治験件数
・ヒトパピローマウイルス(HPV)関連がん:進捗状況別の治験件数
・ヒトパピローマウイルス(HPV)関連がん:スポンサーの種類別治験件数
・ヒトパピローマウイルス(HPV)関連がん:有望なスポンサー
・ヒトパピローマウイルス(HPV)関連がん:有望な薬剤分析
・ヒトパピローマウイルス(HPV)関連がん:主要企業分析
【レポートの概要】

Human Papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Human Papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H2, 2017″ provides an overview of Human Papillomavirus (HPV) Associated Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Human Papillomavirus (HPV) Associated Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Human Papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Human Papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profile Snapshots 31
Appendix 98
Abbreviations 98
Definitions 98
Research Methodology 99
Secondary Research 99
About GlobalData 100
Contact Us 100
Disclaimer 100
Source 101

List of Tables
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Region, 2017* 7
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 14
Proportion of Human Papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 15
Human Papillomavirus (HPV) Associated Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Human Papillomavirus (HPV) Associated Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Human Papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 18
Human Papillomavirus (HPV) Associated Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Human Papillomavirus (HPV) Associated Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Phase, 2017* 21
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Human Papillomavirus (HPV) Associated Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30

List of Figures
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 14
Proportion of Human Papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 15
Human Papillomavirus (HPV) Associated Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Human Papillomavirus (HPV) Associated Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Human Papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 18
Human Papillomavirus (HPV) Associated Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Human Papillomavirus (HPV) Associated Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
Human Papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Human Papillomavirus (HPV) Associated Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Human Papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
GlobalData Methodology 99

【掲載企業】

Merck & Co Inc
GlaxoSmithKline Plc
Advaxis Inc
Genexine Inc
AstraZeneca Plc
PDS Biotechnology Corp
Lee's Pharmaceutical Holdings Ltd
Antiva Biosciences Inc
E. Merck KG
Bristol-Myers Squibb Co

【レポートのキーワード】

ヒトパピローマウイルス(HPV)関連がん、治験、臨床試験、治療薬

★調査レポート[ヒトパピローマウイルス(HPV)関連がん:世界の治験レビュー(2017年下半期版)] (コード:GDHC4600CTIDB)販売に関する免責事項を必ずご確認ください。
★調査レポート[ヒトパピローマウイルス(HPV)関連がん:世界の治験レビュー(2017年下半期版)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆